Patient-education content with affiliate links. Not medical advice. Read disclaimer →

Medical & Affiliate Disclaimer

Medical disclaimer

saxenda.us.com provides patient-education content only. It is not medical advice, diagnosis, or treatment. The information on this website is not a substitute for the professional judgment of a licensed healthcare provider. Always consult a qualified physician, nurse practitioner, pharmacist, or other licensed clinician before starting, stopping, switching, or changing the dose of any medication, including Saxenda (liraglutide).

Individual results vary. Weight-loss percentages cited on this site are averages from published clinical trials (such as the SCALE program for Saxenda, the STEP trials for Wegovy, and the SURMOUNT trials for Zepbound) and may not reflect typical individual outcomes. Drug response depends on many factors, including starting weight, diet, physical activity, concomitant medications, and individual biology.

If you are experiencing a medical emergency, stop reading and call 911 or your local emergency services immediately.

Affiliate disclosure

saxenda.us.com contains affiliate links to third-party telehealth providers and related services. If you click one of these links and complete a qualifying enrollment, we may earn a commission at no additional cost to you. The commission is paid by the telehealth provider, not by you.

Affiliate relationships do not influence the clinical information presented on this site. When we compare Saxenda to newer GLP-1 medications and suggest that newer options may be more effective for most patients, that recommendation is based on published head-to-head clinical trial data (SCALE vs STEP-1 vs SURMOUNT-1), not on commercial incentives.

We disclose affiliate relationships in compliance with the US Federal Trade Commission's Guides Concerning the Use of Endorsements and Testimonials in Advertising.

Drug information and trademarks

Saxenda® and Victoza® are registered trademarks of Novo Nordisk A/S. Wegovy® and Ozempic® are also trademarks of Novo Nordisk. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other trademarks are the property of their respective owners.

saxenda.us.com is an independent educational website and is not affiliated with, endorsed by, or sponsored by Novo Nordisk, Eli Lilly, or any other pharmaceutical manufacturer. Our use of these brand names is for descriptive and comparative purposes only and constitutes fair use for the purpose of patient education.

Comparison disclaimer

Drug comparisons on this site are based on published clinical trial data, FDA-approved labeling, and publicly available pricing data. Prices quoted are averages and may vary by pharmacy, region, insurance status, and coupon eligibility. Individual response to any medication varies, and the choice of medication should always be made in consultation with a qualified healthcare provider based on your individual health status, medical history, and treatment goals.

Telehealth disclosure

The telehealth services we link to are operated by independent companies licensed to provide medical services in the United States. Any medical care you receive through a linked telehealth provider is provided by that provider, not by saxenda.us.com. saxenda.us.com does not provide medical services, does not prescribe medications, and does not operate a pharmacy.

Accuracy and updates

We make reasonable efforts to keep the information on this site accurate and current. However, drug labeling, pricing, and clinical guidelines change frequently. We cannot guarantee that every figure on every page is up to date at the moment you read it. Always verify critical information (especially dosing and pricing) with your prescriber and pharmacist before acting on it.

Changes to this disclaimer

We may update this disclaimer from time to time to reflect changes in our business practices or legal requirements. The most current version is always available at this URL.

Last updated: April 2026.